Cargando…
Membrane Phenotypic, Metabolic and Genotypic Adaptations of Streptococcus oralis Strains Destined to Rapidly Develop Stable, High-Level Daptomycin Resistance during Daptomycin Exposures
The Streptococcus mitis-oralis subgroup of viridans group streptococci are important human pathogens. We previously showed that a substantial portion of S. mitis-oralis strains (>25%) are ‘destined’ to develop rapid, high-level, and stable daptomycin (DAP) resistance (DAP-R) during DAP exposures...
Autores principales: | Mishra, Nagendra N., de Paula Baptista, Rodrigo, Tran, Truc T., Lapitan, Christian K., Garcia-de-la-Maria, Cristina, Miró, Jose M., Proctor, Richard A., Bayer, Arnold S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376253/ https://www.ncbi.nlm.nih.gov/pubmed/37508179 http://dx.doi.org/10.3390/antibiotics12071083 |
Ejemplares similares
-
Strain-Specific Adaptations of Streptococcus mitis-oralis to Serial In Vitro Passage in Daptomycin (DAP): Genotypic and Phenotypic Characteristics
por: Mishra, Nagendra N., et al.
Publicado: (2020) -
1403. Daptomycin Combined with Low Dose Ceftriaxone Prevents the Emergence of Daptomycin Resistance against Streptococcus mitis-oralis Group in an In vitro Model of Simulated Endocardial Vegetations (SEVs)
por: Kebriaei, Razieh, et al.
Publicado: (2018) -
Metabolic changes associated with adaptive resistance to daptomycin in Streptococcus mitis-oralis
por: Parrett, Allison, et al.
Publicado: (2020) -
Mechanistic Fingerprinting Reveals Kinetic Signatures of Resistance to Daptomycin and Host Defense Peptides in Streptococcus mitis-oralis
por: Yeaman, Michael R., et al.
Publicado: (2021) -
1703. Efficacy of Selected Metabolic Inhibitors for the Prevention and Resensitization of High-Level Daptomycin Resistance in Streptococcus mitis-oralis In Vitro and in an Ex Vivo Simulated Endocarditis Model
por: Kebriaei, Razieh, et al.
Publicado: (2022)